Epclusa Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with Epclusa
L
- lamivudine / tenofovir
- Lanoxicaps (digoxin)
- Lanoxin (digoxin)
- lansoprazole
- lansoprazole / naproxen
- Lantus (insulin glargine)
- Lantus OptiClik Cartridge (insulin glargine)
- Lantus SoloStar (insulin glargine)
- lasmiditan
- Leader Heartburn Relief (cimetidine)
- lemborexant
- lenacapavir
- Lente Iletin II (insulin zinc)
- letermovir
- letrozole / ribociclib
- Levemir (insulin detemir)
- levoketoconazole
- Levsin with Phenobarbital (hyoscyamine / phenobarbital)
- lidocaine / sodium bicarbonate
- linagliptin
- linagliptin / metformin
- Lipitor (atorvastatin)
- Liptruzet (atorvastatin / ezetimibe)
- Liqui-Dual Citra (citric acid/sodium citrate)
- liraglutide
- Litfulo (ritlecitinib)
- lixisenatide
- LoCort (dexamethasone)
- Lodoco (colchicine)
- lonapegsomatropin
- Lorbrena (lorlatinib)
- lorlatinib
- Losospan (magaldrate)
- Losospan Plus (magaldrate / simethicone)
- lovastatin
- lovastatin / niacin
- Lowsium (magaldrate)
- Lowsium Plus (magaldrate / simethicone)
- Lufyllin-EPG (dyphylline / ephedrine / guaifenesin / phenobarbital)
- Lumakras (sotorasib)
- Luminal (phenobarbital)
- lusutrombopag
- Lynparza (olaparib)
- Lypqozet (atorvastatin / ezetimibe)
- Lysodren (mitotane)
- Lyumjev (insulin lispro)
More about Epclusa (sofosbuvir / velpatasvir)
- Epclusa consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (388)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: antiviral combinations
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.